APOE and Alzheimer disease: In addition, the cluster-derived normal group had fewer APOE-ε4 carriers and fewer individuals with positive CSF biomarkers of AD than the MCI groups and was also less likely to progress to AD and more likely to revert to normal than the MCI groups [47].